The T2D drugs, rosiglitazone (RSG, trade name Avandia®) and pioglitazone (trade name ActosTM), are members of the thiazolidinedione (TZD) drug class that improve insulin sensitivity in T2D patients (PubChem, 2005). Here, INS is linked to type 2 diabetes mellitus.